Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
OSI Pharmaceuticals Inc. (OSIP)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: OSIP
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Top Authors
Most frequent coverage on OSIP
Alan Brochstein
(709 followers)
Cancer Stocks: Lagging Again
(Mon, Jul 16)
Cancer Stocks Hammered Once Again
(Tue, Jun 26)
Cancer Stocks Slide Again
(Mon, Jun 18)
More by Alan Brochstein on OSIP »
Mike Huckman
(225 followers)
Big Pharma's Pheeding Phrenzy
(Thu, May 28)
Can Steve Jobs's Case Help Propel Biopharma?
(Fri, Jan 16)
AstraZeneca Trials Provide Zest and Zeal for OSI Pharmaceuticals
(Thu, Nov 20)
More by Mike Huckman on OSIP »
Mike Havrilla
(1923 followers)
FDA Calendar Updates: BioMarin, OSI, Roche, Abraxis, Johnson & Johnson
(Tue, Jul 14)
Seven Laggard Biotech Trades
(Thu, Jun 18)
FDA, Clinical Trial Calendars: Cancer Drug Updates from ASCO
(Mon, Jun 1)
More by Mike Havrilla on OSIP »
Most followed authors on OSIP
TraderMark
(3724 followers)
Galleon's Top 10 Holdings
(Tue, Oct 20)
More by TraderMark on OSIP »
SA Editor Rachael Granby
(2020 followers)
Wall Street Breakfast: Must-Know News
(Thu, Jul 23)
Wall Street Breakfast: Must-Know News
(Fri, Feb 20)
More by SA Editor Rachael Granby on OSIP »
Market Folly
(1978 followers)
Galleon Bets Heavily on the S&P 500
(Tue, Jun 9)
More by Market Folly on OSIP »
Newest authors on OSIP
AlphaClone
(522 followers)
Galleon Group's 50 Largest Holdings
(Sun, Oct 18)
More by AlphaClone on OSIP »
Justin M. Hall
(672 followers)
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
(Sun, Sep 20)
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up
(Fri, Sep 11)
More by Justin M. Hall on OSIP »
Prohost Biotech
(88 followers)
OSI: Tarceva Approved as Maintenance Treatment for Lung Cancer
(Tue, Jul 14)
More by Prohost Biotech on OSIP »
Most commented on OSIP
Justin M. Hall
(672 followers)
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
(Sun, Sep 20)
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up
(Fri, Sep 11)
More by Justin M. Hall on OSIP »
SA Editor Rachael Granby
(2020 followers)
Wall Street Breakfast: Must-Know News
(Thu, Jul 23)
Wall Street Breakfast: Must-Know News
(Fri, Feb 20)
More by SA Editor Rachael Granby on OSIP »
Alan Brochstein
(709 followers)
Cancer Stocks: Lagging Again
(Mon, Jul 16)
Cancer Stocks Hammered Once Again
(Tue, Jun 26)
Cancer Stocks Slide Again
(Mon, Jun 18)
More by Alan Brochstein on OSIP »